   |
|
 Case Study Adenocarcinoma in Situ (AIS) of the cervix is often thought of as a rare diagnosis; however, it appears to be on the rise. This case is that of a patient of childbearing age who strongly desired preservation of fertility, and thus, was managed conservatively. 
Journal Review Highlights In this new study out of France, Vaccarella and colleagues show an approximately two-fold risk of HPV positivity in women who reported smoking more than 15 cigarettes daily as compared with women who had never smoked.  |
|
 
HPV Vaccination: Barriers to Routine Implementation The HPV vaccine could prevent up to 70% of cervical cancers, so why is there still reluctance to pass legislation related to the HPV vaccines? How do we combat these resistances and ensure women protection against vaccine-preventable diseases? |
|
 
Dismantling of the U.S. Cytotechnology Educational Infrastructure is Premature and Carries Significant Risks The decline in number of schools of cytotechnology from a historical high of 120 to now roughly 37 is causing concern over whether or not the U.S. will have an adequate cytotechnologist workforce in the very near future. Schools of cytotechnology are a valuable resource in the ongoing efforts for cervical cancer screening and detection of nongynecologic cancers. Support of cytotechnology school infrastructure in the United States is important to ensure an adequate and appropriately-trained cytotechnology workforce. |
|
 |
|